From: Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration
Characteristics | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
B | P | HR | 95%CI | B | P | HR | 95%CI | |
Gender | −0.439 | 0.228 | 0.645 | 0.316–1.315 | −0.096 | 0.803 | 0.908 | 0.426–1.936 |
Age | −0.103 | 0.692 | 0.902 | 0.541–1.503 | −0.390 | 0.178 | 0.677 | 0.384–1.194 |
Differentiation (poor vs. well+moderate) | 0.237 | 0.384 | 1.267 | 0.743–2.160 | 0.283 | 0.326 | 1.327 | 0.755–2.333 |
pT stage (T1 + T2 vs. T3) | 0.566 | 0.082 | 1.762 | 0.931–3.334 | 0.362 | 0.311 | 1.436 | 0.713–2.894 |
Lymph node metastasis | 0.783 | 0.004* | 2.188 | 1.281–3.736 | 0.578 | 0.039* | 1.783 | 1.031–3.082 |
TNM stage (I + II vs. III + IV) | 0.526 | 0.056 | 1.692 | 0.986–2.903 | −0.204 | 0.661 | 0.816 | 0.328–2.027 |
Stromal FN content | 1.034 | 0.000* | 2.813 | 1.648–4.804 | 0.915 | 0.001* | 2.498 | 1.444–4.319 |